Bone mass, biochemical markers and growth in children with chronic kidney disease: A 1-year prospective study

Acta Paediatrica, International Journal of Paediatrics

Volumn 96, Issue 5, 2007, Pages 720-725

  Swolin Eide, Diana ^a   Magnusson, Per ^b,c   Hansson, Sverker ^a  

^a QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bone turnover; DXA; Pediatric; Renal osteodystrophy; Skeleton

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; COLLAGEN TYPE 1; LEPTIN; OSTEOCALCIN; OSTEOPROTEGERIN; PARATHYROID HORMONE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; TELOPEPTIDE; VITAMIN D;

ADOLESCENT; ADULT; ARTICLE; BODY COMPOSITION; BONE AGE; BONE DENSITY; BONE MASS; BONE TURNOVER; CHILD; CHILD GROWTH; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; DIET; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; HUMAN; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE;

ACID PHOSPHATASE; ADOLESCENT; BIOLOGICAL MARKERS; BONE DENSITY; CHILD; CHILD, PRESCHOOL; COLLAGEN TYPE I; FEMALE; HUMANS; ISOENZYMES; LEPTIN; MALE; PARATHYROID HORMONE; PEPTIDES; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC;

EID: 34247537528     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2007.00236.x     Document Type: Article

References (29)

1. Heaney RP, Abrams S, Dawson-Hughes B, Looker A, Marcus R, Matkovic V, et al. Peak bone mass. Osteoporos Int 2000 11 : 985 1009.
2. Hruska K. Pathophysiology of renal osteodystrophy. Pediatr Nephrol 2000 333 : 166 74.
3. Kuizon BD, Salusky IB. Renal osteodystrophy: pathogenesis, diagnosis, and treatment. In : Glorieux FH, Pettifor JM, Jüppner H, editors. Pediatric bone. Biology and diseases. London : Academic Press, 2003 : 679 701.
4. Klaus G, Watson A, Edefonti A, Fischbach M, Rönnholm K, Schaefer F, et al. Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines. Pediatr Nephrol 2006 21 : 151 9.
5. Ziolkowska H, Panczyk-Tomaszewska M, Majkowska Z, Rajkowski T, Debinski A, Przedlacki J, et al. Imaging of bone in the diagnostics of renal osteodystrophy in children with chronic renal failure. Med Sci Monit 2001 7 : 1034 42.
6. Pluskiewicz W, Adamczyk P, Drozdzowska B, Szprynger K, Szczepanska M, Halaba Z, et al. Skeletal status in children and adolescents with chronic renal failure before onset of dialysis or on dialysis. Osteoporos Int 2003 14 : 283 8.
7. Groothoff JW, Offringa M, van Eck-Smit BLF, Gruppen MP, van de Kar NJ, Wolff ED, et al. Severe bone disease and low bone mineral density after juvenile renal failure. Kidney Int 2003 63 : 266 75.
8. Bakr AM. Bone mineral density and bone turnover markers in children with chronic renal failure. Pediatr Nephrol 2004 19 : 1390 3.
9. Cunningham J, Sprague SM, Cannata-Andia J, Coco M, Cohen-Solal M, Fitzpatrick L, et al. Osteoporosis in chronic kidney disease. Am J Kidney Dis 2004 43 : 566 71.
10. Tönshoff B, Kiepe D, Ciarmatori S. Growth hormone/insulin-like growth factor system in children with chronic renal failure. Pediatr Nephrol 2005 20 : 279 89.
11. Schwartz GJ, Haycock GB, Edelmann Jr. CM, Spitzer A. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976 58 : 259 69.
12. Sandström B, Aro A, Becker W, Lyhne N, Pedersen JI, Thorsdottir I. Nordic Nutrition Recommendations 1996. Copenhagen, Denmark : Nordic Council of Ministers, 1996.
13. Hakulinen MA, Saarakkala S, Töyräs J, Kröger H, Jurvelin JS. Dual energy X-ray laser measurement of calcaneal bone mineral density. Phys Med Biol 2003 48 : 1741 52.
14. Kullenberg R, Falch JA. Prevalence of osteoporosis using bone mineral measurements at the calcaneus by dual X-ray and laser (DXL). Osteoporos Int 2003 14 : 823 7.
15. Martini G, Valenti R, Gennari L, Salvadori S, Galli B, Nuti R. Dual X-ray and laser absorptiometry of the calcaneus: comparison with quantitative ultrasound and dual-energy X-ray absorptiometry. J Clin Densitom 2004 7 : 349 54.
16. Söderpalm A-C, Kullenberg R, Albertsson Wikland K, Swolin-Eide D. Pediatric reference data for bone mineral density in the calcaneus for healthy children 2, 4, and 7 years of age by dual-energy X-ray absorptiometry and laser. J Clin Densitom 2005 8 : 305 13.
17. Swolin-Eide D, Hansson S, Larsson L, Magnusson P. The novel bone alkaline phosphatase B1x isoform in children with kidney disease. Pediatr Nephrol 2006, 21 : 1723 29.
18. Löfqvist C, Andersson E, Gelander L, Rosberg S, Hulthen L, Blum WF, et al. Reference values for insulin-like growth factor-binding protein-3 (IGFBP-3) and the ratio of insulin-like growth factor-I to IGFBP-3 throughout childhood and adolescence. J Clin Endocrinol Metab 2005 90 : 1420 7.
19. Albertsson-Wikland K, Karlberg J. Natural growth in children born small for gestational age with and without catch-up growth. Acta Paediatr 1994 (Suppl. 399 64 70.
20. Carlsson B, Ankarberg C, Rosberg S, Norjavaara E, Albertsson-Wikland K, Carlsson LMS. Serum leptin concentrations in relation to pubertal development. Arch Dis Child 1997 77 : 396 400.
21. Kröger H, Kotaniemi A, Vainio P, Alhava E. Bone densitometry of the spine and femur in children by dual-energy X-ray absorptiometry. Bone Miner 1992 17 : 75 85.
22. Reid IR. Relationships among body mass, its components, and bone. Bone 2002 31 : 547 55.
23. Polak-Jonkisz D, Zwolinska D, Bednorz R, Owczarek H, Szymanska A, Nahaczewska W. Procollagen I carboxyterminal propeptide (PICP) as a bone formation marker and carboxyterminal telopeptide of type I collagen (ICTP) as a bone degradation marker in children with chronic renal failure under conservative therapy. Med Sci Monit 2003 9 : CR19 23.
24. Baskin E, Besbas N, Saatci Ü, Hascelik G, Topaloglu R, Özen S, et al. Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children. Turk J Pediatr 2004 46 : 28 31.
25. Tsuchida T, Ishimura E, Miki T, Matsumoto N, Naka H, Jono S, et al. The clinical significance of serum osteocalcin and N-terminal propeptide of type I collagen in predialysis patients with chronic renal failure. Osteoporos Int 2005 16 : 172 9.
26. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 2000 100 : 197 207.
27. Besbas N, Ozaltin F, Coskun T, Özalp S, Saatci U, Bakkaloglu A, et al. Relationship of leptin and insulin-like growth factor I to nutritional status in hemodialyzed children. Pediatr Nephrol 2003 18 : 1255 9.
28. Daschner M, Tönshoff B, Blum WF, Englaro P, Wingen A-M, Schaefer F, et al. Inappropriate elevation of serum leptin levels in children with chronic renal failure. European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. J Am Soc Nephrol 1998 9 : 1074 9.
29. Mak RH, Cheung W, Cone RD, Marks DL. Leptin and inflammation-associated cachexia in chronic kidney disease. Kidney Int 2006 69 : 794 7.